Caprock Group LLC Sells 7,473 Shares of Waters Co. (NYSE:WAT)

Caprock Group LLC reduced its holdings in shares of Waters Co. (NYSE:WATFree Report) by 91.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 714 shares of the medical instruments supplier’s stock after selling 7,473 shares during the quarter. Caprock Group LLC’s holdings in Waters were worth $235,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in WAT. Vanguard Group Inc. boosted its holdings in shares of Waters by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 6,689,208 shares of the medical instruments supplier’s stock valued at $2,076,263,000 after buying an additional 30,274 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Waters by 1.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,520,629 shares of the medical instruments supplier’s stock valued at $965,392,000 after purchasing an additional 48,740 shares during the last quarter. State Street Corp lifted its holdings in Waters by 1.2% during the 2nd quarter. State Street Corp now owns 2,619,676 shares of the medical instruments supplier’s stock valued at $698,248,000 after purchasing an additional 29,920 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Waters by 37.2% during the 2nd quarter. Alliancebernstein L.P. now owns 2,018,487 shares of the medical instruments supplier’s stock valued at $538,008,000 after purchasing an additional 547,777 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in Waters by 79.6% during the 1st quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock valued at $467,011,000 after purchasing an additional 666,851 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Stock Performance

Shares of WAT stock opened at $339.69 on Wednesday. The business’s 50-day moving average price is $335.16 and its 200-day moving average price is $301.21. Waters Co. has a 12 month low of $231.90 and a 12 month high of $363.80. The firm has a market capitalization of $20.11 billion, a price-to-earnings ratio of 31.31, a PEG ratio of 6.85 and a beta of 0.92. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. The firm had revenue of $819.50 million for the quarter, compared to analyst estimates of $815.50 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. The business’s revenue for the quarter was down 4.5% on a year-over-year basis. During the same period last year, the firm posted $3.84 earnings per share. Equities research analysts forecast that Waters Co. will post 11.89 EPS for the current year.

Analysts Set New Price Targets

WAT has been the subject of several research reports. Citigroup raised their price target on Waters from $265.00 to $300.00 and gave the company a “neutral” rating in a report on Monday, December 11th. Barclays lifted their target price on Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a report on Monday, February 12th. TheStreet upgraded Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. Stifel Nicolaus raised their price target on Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research report on Wednesday, February 7th. Finally, Wolfe Research assumed coverage on Waters in a research report on Wednesday, December 13th. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Based on data from MarketBeat.com, Waters presently has a consensus rating of “Hold” and an average price target of $293.50.

Read Our Latest Stock Analysis on WAT

Insider Buying and Selling

In related news, Director Linda Baddour sold 500 shares of Waters stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the transaction, the director now directly owns 2,250 shares of the company’s stock, valued at $799,965. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.77% of the stock is owned by insiders.

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.